Can a smartphone program help heavy smokers quit and get lifesaving scans?
NCT ID NCT04691297
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called ESCAPE that combines counseling, nicotine replacement, digital videos, and lung screening education to help high-risk smokers quit. It involves 153 smokers aged 55-77 with a heavy smoking history. The program is compared to standard care (brief advice and a quitline referral). The goal is to see if the digital approach leads to more people quitting and getting screened for lung cancer.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral counseling, nicotine replacement therapy, digital storytelling videos, and lung screening education
- What this could lead to
- If successful, this program could help high-risk smokers quit more effectively and increase lung cancer screening rates, potentially reducing lung cancer deaths.
- What could go wrong
- This is a small Phase II trial with only 153 participants, so results may not apply to everyone. The program's success depends on participants engaging with digital tools, which may not work for all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
153 people
The number who actually took part.
- Started
-
Feb 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 to 77 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 55 to 77 years of age * No previous history of lung cancer * ECOG performance status \< 2 * ≥ 30 pack year smoking history * Smoke ≥ 5 cigarettes/day * Own a mobile phone with access to a video call application * Has a primary care provider (PCP) * Provide contact information for the PCP * Active health insurance * Has not had LDCT screening * English speaking * Can complete an interview Exclusion Criteria: * Hospitalization for severe mental illness within the last year. * The following special populations will not be included * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung cancer screening are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Can an AI chatbot help cancer patients kick the habit?
- Does the clock matter? scientists randomize when Quit-Smoking chatbots ping you
- Gum fluid proteins eyed as link between smoking and periodontitis
- Can a WhatsApp message help smokers quit?
- An animated video takes aim at missed lung cancer screening